Ryan Specialty Holdings, Inc. RYAN
This picture changes. Follow Ryan Specialty Holdings, Inc. free — email when the signal or risk changes + a Sunday weekly brief.
Follow Ryan Specialty Holdings, Inc. freeEmail when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Full analysis: 31 Jul 2026
Latest news check: 7 Jun 2026
General analysis — not personal advice.
HOLD
7/10
Confidence
Existing position can be maintained pending Q3 confirmation of margin trends.
Stable organic growth and positive Q2 results are balanced against high leverage and execution risks in the Empower program.
Market sentiment
7/10
↑
Trend: Improving
The market is reacting positively to the strong Q2 results and raised margin guidance.
Price context
The share closed at 44.09 USD after a 43 percent rally over the past three months, indicating the market is already pricing in a recovery from the prior decline off the 52-week high.
Risk assessment
6/10
Dilution:
Low
Ongoing share buybacks reduce dilution pressure
Jurisdiction:
Low
Operations primarily in the US and UK
Execution:
Medium
M&A integration and Empower program require continued focus
About the company
Ryan Specialty is a leading wholesale broker and managing general underwriter in specialty insurance. The company places complex risks between retail brokers and carriers with a focus on the E&S market.
Sector:
Specialty insurance brokerage
Type:
Finance
Next report
15 Oct 2026
Q3
Catalysts
Q4 2026
Q3 2026 report
High
Unknown
New M&A acquisitions
Medium
Horizon:
Bull case
Strong organic growth and Empower program savings can lift margins after the Q2 beat.
Bear case
High leverage and M&A integration risks may limit flexibility if organic growth slows.
Sensitivity analysis
| Factor | If it weakens | If it strengthens |
|---|---|---|
| Empower program savings | Delayed savings → margin improvement fails to materialize and 2026 profitability target is missed. | Faster savings → adjusted EBITDAC margin rises toward 36 percent and cash flow strengthens. |
| Organic growth in the E&S segment | Growth falls below 6 percent → revenue guidance is revised lower and market confidence declines. | Growth exceeds 8 percent → revenue accelerates and the company gains market share. |
We monitor these factors. Follow the company to get email when any of them hit.
Signal rationale (informational)
Stable organic growth and positive Q2 results are balanced against high leverage and execution risks in the Empower program.
Recent news
- The Q2 2026 report released on 30 July showed revenue of 916.6 million USD and adjusted EBITDAC of 326.9 million USD, beating expectations. The company returned 284.5 million USD to shareholders via buybacks and raised full-year guidance.
Key figures
Revenue
Q2 2026
USD 917M
Revenue TTM
TTM
USD 3.1B
EBITDA
Q2 2026
USD 327M
Net income
Q2 2026
USD 108M
Cash
Q1 2026
USD 155M
Total debt
Q1 2026
USD 3,670M
Shares outstanding
Q2 2026
264M
EPS
Q2 2026
USD 0.41
Price & valuation
Last close
USD 42.32
Market Cap
USD 11.2B
1 week
-5.7 %
3 months
+39.8 %
12 months
-28.9 %
From 52w high
-30.6 %
From 52w low
+44.0 %
Exchange
NYSE
Type
Finance
Sector
Specialty insurance brokerage
This picture changes. Follow Ryan Specialty Holdings, Inc. free — email when the signal or risk changes + a Sunday weekly brief.
Follow 3 companies freeEmail when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.